Enliven Therapeutics, Inc.ELVNNASDAQ
Loading
Total Assets Over TimeExpanding
Percentile Rank100
3Y CAGR+78.8%
5Y CAGR+39.3%
Year-over-Year Change
Total value of everything the company owns
3Y CAGR
+78.8%/yr
vs +81.3%/yr prior
5Y CAGR
+39.3%/yr
Recent acceleration
Acceleration
-2.5pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
5.2x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $476.17M | +46.2% |
| 2024 | $325.76M | +19.8% |
| 2023 | $271.87M | +226.4% |
| 2022 | $83.30M | -26.5% |
| 2021 | $113.33M | +24.8% |
| 2020 | $90.84M | +172.8% |
| 2019 | $33.30M | +332.2% |
| 2018 | $7.71M | -24.6% |
| 2017 | $10.22M | - |